(LTC) LTC Properties - Overview
Stock: Seniors Housing, Skilled Nursing, Triple-Net, Joint Ventures
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.46% |
| Yield on Cost 5y | 8.91% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.4% |
| Payout Ratio | 1.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.6% |
| Relative Tail Risk | 2.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.72 |
| Alpha | 9.52 |
| Character TTM | |
|---|---|
| Beta | 0.141 |
| Beta Downside | 0.019 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.75% |
| CAGR/Max DD | 0.42 |
Description: LTC LTC Properties January 15, 2026
LTC Properties Inc. (NYSE:LTC) is a U.S.-based REIT that specializes in senior housing and health-care real estate, deploying capital through its RIDEA platform, triple-net leases, joint ventures, and structured-finance solutions. The portfolio comprises roughly 190 properties in about 25 states, operated by more than 31 partners, with senior-housing communities representing ~62% of gross real-estate investments and skilled-nursing centers the balance.
Key metrics as of the latest filing: occupancy across the senior-housing segment averaged 89.5%, while the average rent growth YoY was 3.2%, reflecting modest demand pressure. The REIT’s weighted-average lease term is 7.8 years, providing relatively stable cash flow in a sector where demographic trends (the aging Baby-Boom cohort) drive long-term demand for senior-care space.
Sector drivers include rising Medicare-linked reimbursement rates and the ongoing shortage of skilled-nursing capacity, which together support rent escalations and lower vacancy risk for operators with strong partnership networks.
For a deeper, data-rich analysis of LTC’s valuation dynamics, you might find ValueRay’s platform useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 33.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.15 > 1.0 |
| NWC/Revenue: 201.9% < 20% (prev 287.8%; Δ -85.91% < -1%) |
| CFO/TA 0.06 > 3% & CFO 131.3m > Net Income 33.9m |
| Net Debt (929.2m) to EBITDA (109.0m): 8.53 < 3 |
| Current Ratio: 21.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.1m) vs 12m ago 3.89% < -2% |
| Gross Margin: 83.40% > 18% (prev 0.94%; Δ 8246 % > 0.5%) |
| Asset Turnover: 11.80% > 50% (prev 11.08%; Δ 0.72% > 0%) |
| Interest Coverage Ratio: 2.20 > 6 (EBITDA TTM 109.0m / Interest Expense TTM 33.1m) |
Altman Z'' 1.04
| A: 0.23 (Total Current Assets 488.9m - Total Current Liabilities 22.3m) / Total Assets 2.04b |
| B: -0.09 (Retained Earnings -190.6m / Total Assets 2.04b) |
| C: 0.04 (EBIT TTM 72.9m / Avg Total Assets 1.96b) |
| D: -0.38 (Book Value of Equity -379.4m / Total Liabilities 999.2m) |
| Altman-Z'' Score: 1.04 = BB |
Beneish M 0.23
| DSRI: 0.02 (Receivables 20.5m/847.0m, Revenue 231.1m/207.5m) |
| GMI: 1.12 (GM 83.40% / 93.57%) |
| AQI: 7.60 (AQ_t 0.21 / AQ_t-1 0.03) |
| SGI: 1.11 (Revenue 231.1m / 207.5m) |
| TATA: -0.05 (NI 33.9m - CFO 131.3m) / TA 2.04b) |
| Beneish M-Score: 0.23 (Cap -4..+1) = D |
What is the price of LTC shares?
Over the past week, the price has changed by +2.52%, over one month by +6.12%, over three months by +6.96% and over the past year by +15.95%.
Is LTC a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the LTC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.1 | 2% |
| Analysts Target Price | 38.1 | 2% |
| ValueRay Target Price | 42.3 | 13.1% |
LTC Fundamental Data Overview February 05, 2026
P/E Forward = 12.4533
P/S = 7.6145
P/B = 1.8129
P/EG = 5.41
Revenue TTM = 231.1m USD
EBIT TTM = 72.9m USD
EBITDA TTM = 109.0m USD
Long Term Debt = 396.1m USD (from longTermDebt, last quarter)
Short Term Debt = 944.5m USD (from shortTermDebt, last quarter)
Debt = 947.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 929.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.66b USD (1.73b + Debt 947.2m - CCE 17.9m)
Interest Coverage Ratio = 2.20 (Ebit TTM 72.9m / Interest Expense TTM 33.1m)
EV/FCF = 20.24x (Enterprise Value 2.66b / FCF TTM 131.3m)
FCF Yield = 4.94% (FCF TTM 131.3m / Enterprise Value 2.66b)
FCF Margin = 56.82% (FCF TTM 131.3m / Revenue TTM 231.1m)
Net Margin = 14.65% (Net Income TTM 33.9m / Revenue TTM 231.1m)
Gross Margin = 83.40% ((Revenue TTM 231.1m - Cost of Revenue TTM 38.4m) / Revenue TTM)
Gross Margin QoQ = 71.22% (prev 79.72%)
Tobins Q-Ratio = 1.30 (Enterprise Value 2.66b / Total Assets 2.04b)
Interest Expense / Debt = 0.93% (Interest Expense 8.79m / Debt 947.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 57.6m (EBIT 72.9m * (1 - 21.00%))
Current Ratio = 21.93 (Total Current Assets 488.9m / Total Current Liabilities 22.3m)
Debt / Equity = 0.99 (Debt 947.2m / totalStockholderEquity, last quarter 957.9m)
Debt / EBITDA = 8.53 (Net Debt 929.2m / EBITDA 109.0m)
Debt / FCF = 7.08 (Net Debt 929.2m / FCF TTM 131.3m)
Total Stockholder Equity = 959.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.73% (Net Income 33.9m / Total Assets 2.04b)
RoE = 3.53% (Net Income TTM 33.9m / Total Stockholder Equity 959.5m)
RoCE = 5.38% (EBIT 72.9m / Capital Employed (Equity 959.5m + L.T.Debt 396.1m))
RoIC = 3.36% (NOPAT 57.6m / Invested Capital 1.71b)
WACC = 4.42% (E(1.73b)/V(2.68b) * Re(6.44%) + D(947.2m)/V(2.68b) * Rd(0.93%) * (1-Tc(0.21)))
Discount Rate = 6.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 4.74%
[DCF Debug] Terminal Value 87.43% ; FCFF base≈125.7m ; Y1≈141.6m ; Y5≈190.0m
Fair Price DCF = 98.04 (EV 5.60b - Net Debt 929.2m = Equity 4.67b / Shares 47.6m; r=5.90% [WACC]; 5y FCF grow 14.64% → 2.90% )
EPS Correlation: -50.14 | EPS CAGR: -13.76% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.77 | Revenue CAGR: 16.21% | SUE: 0.33 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.91 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+14.7% | Growth Revenue=+70.4%